IDH2 and glioblastoma: The results of the survival analysis showed that the higher expression of miR-9-5p in GBM tissues correlated with a shorter median survival of IDH-mutant GBM patients, whereas in all patients, regardless of the IDH mutation status, a higher miR-9-5p was linked to better survival.